NanoEcho submits application to the authority to start a clinical study
NanoEcho AB (publ), which develops a new diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes, has today submitted an application to the Swedish Medicines Agency to evaluate the company’s medical diagnostic device in a clinical study. In the planned study, NanoEcho’s method will be used and evaluated on patients with […]
Health economic model for introduction of NanoEcho’s diagnostic method: basis for care decisions and pricing strategy
NanoEcho has, in collaboration with health economic experts, developed a model for health economic analysis of the introduction of NanoEcho’s method in healthcare, with the aim of investigating the potential cost-effectiveness. The health economic model shows that the introduction of NanoEcho’s diagnostic method has the potential to generate health economic gains. This analysis will form […]
NanoEcho has entered into an agreement securing the supply of nanoparticles
Today, NanoEcho has entered into a comprehensive agreement ensuring the company’s access to iron oxide-based nanoparticles, Ferrotran® (ferumoxtran), both in the short and long term. The agreement with SPL Medical represents the company’s most significant deal to date, as the choice of nanoparticles is crucial for the optimal functioning of the company’s diagnostic method. The […]
NanoEcho awarded external innovation grant for market analysis
NanoEcho has been awarded an innovation grant from Vinnova of SEK 99,000 within the scope of business development. The awarded grant is intended to finance a market analysis of potential customer segments. Vinnova’s innovation support aims to strengthen small and medium-sized companies’ innovation capacity and competitiveness. NanoEcho has been awarded a grant of SEK 99,000 […]
NanoEcho is awarded grant for innovative growth
NanoEcho has been awarded a grant from the SME (Small and Medium Enterprises) -fund within the European Union Intellectual Property Office to cover initial fees related to a new patent application and trademark protection. These grants are provided to support the management of intellectual property assets for European SMEs. The SME Fund offers financial support […]
NanoEchos strengthens its position with an approved patent in the USA
NanoEcho’s method has got its patent approved in the USA. This milestone means that NanoEcho’s technology is now protected in the important US market. The patent protects the design of a hand-held probe, which combines ultrasound transducers and magnets placed on the same device. This patent has already been approved in Europe, Japan, South Korea […]
NanoEcho’s technology is presented at a surgeon conference
Images generated with NanoEcho’s system were shown for the first time to internationally leading colorectal surgeons at the annual Swedish conference on colorectal surgery. The Swedish conference on colorectal surgery 2023 took place on April 20 – 21 in Malmö. This is an annual conference organized by the Swedish Association for Colorectal Surgery in collaboration […]
NanoEcho strengthens management by hiring a clinical director
NanoEcho strengthens the organization by hiring Ulrika Axelsson as responsible for the company’s clinical operations. Ulrika will be part of the company’s executive management team and will, among other things, be responsible for planning and carrying out the company’s clinical studies, with the goal of getting market approval for NanoEcho’s system for rectal cancer diagnostics. […]
A new Board has been appointed at NanoEcho – increased focus on commercialization
A new Board that reflects the Company’s development has been appointed. The newly appointed Chairman is Daniel Johnsson, former CEO and founder of, among others, Exertis Nordics, now investor and advisor. A new member of the Company’s Board is PhD and Business Coach Ann-Christin Malmborg Hager. At the Annual General Meeting, NanoEcho elected Daniel Johnsson […]
A historic day – for the first time ever, a magnetomotive ultrasound was applied to human tissue
Yesterday was a historic day for NanoEcho. To our knowledge, this is the first time ever that the magnetomotive ultrasound method has been applied to human tissue. This was carried out on operated cancer tissue using NanoEcho’s first generation portable system at Sahlgrenska University Hospital in Gothenburg. Our system is designed to map, with high […]
